Sep 16, 2019 Checkpoint Therapeutics Announces Data Presentation at the European Society for Medical Oncology (ESMO) Congress 2019
Aug 08, 2019 Checkpoint Therapeutics Reports Second Quarter 2019 Financial Results and Recent Corporate Highlights
May 09, 2019 Checkpoint Therapeutics Reports First Quarter 2019 Financial Results and Recent Corporate Highlights
May 01, 2019 Checkpoint Therapeutics Announces Positive Interim Clinical Results of Anti-PD-L1 Antibody Cosibelimab
Apr 03, 2019 Checkpoint Therapeutics to Present at the 2019 H.C. Wainwright Global Life Sciences Conference
Mar 15, 2019 Checkpoint Therapeutics Reports Full-Year 2018 Financial Results and Recent Corporate Highlights
Jan 07, 2019 Checkpoint Therapeutics Initiates Registrational Development Programs for Anti-PD-L1 Antibody CK-301